Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency

Clemens Küpper1, Johanna Heinrich2, Katharina Kamm2

  • 1From the Department of Neurology (C.K., J.H., K.K., A.S.), University Hospital, Ludwig Maximilians University; Laboratory for Leukemia Diagnostics (V.B.), Department of Medicine III, University Hospital, Ludwig Maximilians University; and Division of Clinical Pharmacology (S.R.), University Hospital, Ludwig Maximilians University, Munich, Germany. Clemens.Kuepper@med.uni-muenchen.de.

Abstract

No abstract available in PubMed .